Diabetic Nephropathy in Spontaneously Type 2 Diabetic Nonhuman Primates (Rhesus Monkeys
            Macaca mulatta
            ): Comparator Validation of Angiotensin Receptor Blocker Valsartan

Nonhuman Primates ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Effect of Combination Therapy with Angiotensin Receptor Blocker and 1,25-Dihydroxyvitamin D3 in Type 2 Diabetic Nephropathy in KK-Ay/Ta Mice

Nephron Experimental Nephrology ◽

10.1159/000320284 ◽

2011 ◽

Vol 117 (4) ◽

pp. 124-132 ◽

Cited By ~ 27

Author(s):

Ikko Ohara ◽

Mitsuo Tanimoto ◽

Tomohito Gohda ◽

Takahiko Yamazaki ◽

Shinji Hagiwara ◽

...

Keyword(s):

Diabetic Nephropathy ◽

Combination Therapy ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3 ◽

Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

Hypertension Research ◽

10.1038/hr.2012.45 ◽

2012 ◽

Vol 35 (8) ◽

pp. 874-881 ◽

Cited By ~ 12

Author(s):

Masanori Abe ◽

Noriaki Maruyama ◽

Hiroko Suzuki ◽

Yuki Fujii ◽

Midori Ito ◽

...

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Diabetic Patients ◽

Angiotensin Receptor ◽

Type 2 Diabetic Patients ◽

Good news for patients with type 2 diabetes: angiotensin receptor blocker treatment delays progression of diabetic nephropathy

Current Opinion in Nephrology & Hypertension ◽

10.1097/00041552-200203000-00007 ◽

2002 ◽

Vol 11 (2) ◽

pp. 173-175

Author(s):

Ernesto L. Schiffrin

Keyword(s):

Type 2 Diabetes ◽

Diabetic Nephropathy ◽

Good News ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Treatment Delays

Combination ofTripterygium wilfordiiHook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease

Biotechnology & Biotechnological Equipment ◽

10.1080/13102818.2014.989727 ◽

2014 ◽

Vol 29 (1) ◽

pp. 139-146 ◽

Cited By ~ 4

Author(s):

Ruixia Ma ◽

Yan Xu ◽

Wei Jiang ◽

Wei Zhang

Keyword(s):

Kidney Disease ◽

Diabetic Kidney Disease ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Diabetic Kidney ◽

Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria

Hypertension Research ◽

10.1038/hr.2011.67 ◽

2011 ◽

Vol 34 (8) ◽

pp. 935-941 ◽

Cited By ~ 21

Author(s):

Masanori Abe ◽

Noriaki Maruyama ◽

Kazuyoshi Okada ◽

Shiro Matsumoto ◽

Koichi Matsumoto ◽

...

Keyword(s):

Receptor Blocker ◽

Diabetic Patients ◽

Angiotensin Receptor ◽

Type 2 Diabetic Patients ◽

Antioxidative Effects ◽

The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice

Vascular Pharmacology ◽

10.1016/j.vph.2015.06.013 ◽

2016 ◽

Vol 76 ◽

pp. 28-36 ◽

Cited By ~ 5

Author(s):

Kathryn E. Husarek ◽

Paige S. Katz ◽

Aaron J. Trask ◽

Maarten L. Galantowicz ◽

Mary J. Cismowski ◽

...

Keyword(s):

Receptor Blocker ◽

Diabetic Mice ◽

Angiotensin Receptor ◽

Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfn770 ◽

2009 ◽

Vol 24 (6) ◽

pp. 1876-1883 ◽

Cited By ~ 27

Author(s):

L. L. Guo ◽

Y. Pan ◽

H. M. Jin

Keyword(s):

Insulin Resistance ◽

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Receptor Blocker ◽

In navigator, the angiotensin receptor blocker valsartin modestly reduced the progression to type 2 diabetes but had no effect on cardiovascular events in higher-risk patients with impaired glucose tolerance

Journal of Clinical Hypertension ◽

10.1111/j.1751-7176.2010.00364.x ◽

2010 ◽

Vol 12 (11) ◽

pp. 881-885 ◽

Cited By ~ 2

Author(s):

Michael J. Bloch ◽

Jan N. Basile

Keyword(s):

Type 2 Diabetes ◽

Glucose Tolerance ◽

Impaired Glucose Tolerance ◽

Cardiovascular Events ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Risk Patients

Effects of Angiotensin Receptor Blocker on Phenotypic Alterations of Podocytes in Early Diabetic Nephropathy

The American Journal of the Medical Sciences ◽

10.1097/maj.0b013e3182010da9 ◽

2011 ◽

Vol 341 (3) ◽

pp. 207-214 ◽

Cited By ~ 14

Author(s):

Hou-Yong Dai ◽

Min Zheng ◽

Ri-Ning Tang ◽

Jie Ni ◽

Kun-Ling Ma ◽

...

Keyword(s):

Diabetic Nephropathy ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Early Diabetic Nephropathy

Renoprotection Provided by Dipeptidyl Peptidase-4 Inhibitors in Combination with Angiotensin Receptor Blockers in Patients with Type 2 Diabetic Nephropathy

Chinese Medical Journal ◽

10.4103/0366-6999.245277 ◽

2018 ◽

Vol 131 (22) ◽

pp. 2658-2665 ◽

Cited By ~ 4

Author(s):

Dan-Dan Qiu ◽

Jing Liu ◽

Jing-Song Shi ◽

Yu An ◽

Yong-Chun Ge ◽

...

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Receptor Blockers ◽

Dipeptidyl Peptidase ◽

Angiotensin Receptor ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Receptor Blockers ◽